MedPath

Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial

Not Applicable
Not yet recruiting
Conditions
Critical Care
Acute Hypoxic Respiratory Failure
Ventilator-Induced Lung Injury
Interventions
Procedure: PMI-targeted pressure support setting and adjustment
Procedure: VT/RR-targeted pressure support setting and adjustment
Registration Number
NCT06526598
Lead Sponsor
Capital Medical University
Brief Summary

The Inspiratory effort-Targeted Pressure Support Ventilation (IT-PSV) is a cluster randomized controlled trial. Its main aim is to determine whether an inspiratory effort-targeted pressure support setting strategy, compared to the traditional tidal volume and respiratory rate target, can improve clinical outcomes in adult participants undergoing pressure support ventilation.

The investigators propose a physiological-oriented assisted ventilation management that, if found effective, could potentially change the clinical practice for mechanical ventilation.

Detailed Description

Pressure-support ventilation (PSV) is widely used in the intensive care unit (ICU). The successful implementation of PSV depends on matching the patient's inspiratory effort with the ventilator support. Traditionally, pressure support levels are set according to tidal volume (VT) and respiratory rate (RR). However, previous studies have shown that over-assistance under PSV is not uncommon based on this setting strategy. Pressure muscle index (PMI) is an inspiratory effort monitoring, which can be easily obtained on the ventilator screen at the bedside.

Aim:

The aim is to determine whether an inspiratory effort-targeted pressure support setting strategy, compared to the traditional approach, can improve clinical outcomes in adult participants undergoing PSV.

Design:

This is a two-arm cluster randomized trial in 16 clusters randomized 1:1 to pressure support setting by a PMI-targeted strategy or a traditional VT/RR-targeted strategy.

Population:

Patients with acute hypoxic respiratory failure who have been intubated within seven days and undergoing PSV within 24 hours will be enrolled.

Intervention:

During the study, a general standard of care for mechanical ventilation will be followed, including the transition of control modes to PSV, the principle PSV settings (trigger, cycle-off, fraction of inspired oxygen, and positive end-expiratory pressure), rescue backup of controlled ventilation, performance of spontaneous breathing trial, and weaning and extubation.

In the VT/RR-targeted group, the pressure support is adjusted to obtain a VT between 6 and 8 ml/kg predicted body weight and RR between 20 and 35 breaths/min.

In the PMI-targeted group, the pressure support is adjusted according to the PMI between 0 and 2 cmH2O.

During the study period in the two groups, pressure support adjustment will be performed at least twice daily.

The intervention will be implemented over 24 months.

Training:

After randomization, a four-week comprehensive training program will be conducted for all staff in the participating ICUs before the formal start of the trial.

Outcomes:

The primary outcome is the total duration of mechanical ventilation. Secondary outcomes include the time before the first spontaneous breathing trial, weaning time, frequency of prolonged and failed weaning, frequency of mechanical ventilation longer than 21 days, length of stay in the ICU and hospital, ICU mortality, hospital mortality, and 28-day mortality.

Study sites:

The study will be conducted in 16 ICUs in university-affiliated hospitals in three provinces in China: Beijing, Tianjin, and Hebei.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
640
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PMI-targeted groupPMI-targeted pressure support setting and adjustmentThe participants will be treated according to the standard of care for mechanical ventilation. During PSV, pressure support is set and adjusted according to the PMI target.
VT/RR-targeted groupVT/RR-targeted pressure support setting and adjustmentThe participants will be treated according to the standard of care for mechanical ventilation. During PSV, pressure support is set and adjusted according to the VT/RR target.
Primary Outcome Measures
NameTimeMethod
Total duration of mechanical ventilation28 days

Defined as the time intervals from intubation and mechanical ventilation to successful weaning. For patients with re-intubation or restoration of mechanical ventilation via tracheostomy within seven days after extubation and discontinuation of ventilation, the thereafter duration will be added.

Secondary Outcome Measures
NameTimeMethod
ICU mortality28 days

Death in the ICU.

Weaning time28 days

Defined as the time from the first SBT attempt to successful discontinuation of mechanical ventilation.

Length of stay in the hospital28 days

Defined as the time interval from enrollment to discharge from hospital or death.

Duration of mechanical ventilation after enrollment28 days

Defined as the time intervals from enrollment to successful weaning. For patients with re-intubation or restoration of mechanical ventilation via tracheostomy within seven days after extubation and discontinuation of ventilation, the thereafter duration will be added.

The time before the first spontaneous breathing trial28 days

Defined as the time interval from intubation and mechanical ventilation to the first spontaneous breathing trial attempt.

Frequency of prolonged weaning28 days

Prolonged weaning is defined as that weaning is still not terminated 7 days after the first separation attempt.

Hospital mortality28 days

Death in the hospital.

Length of stay in the ICU28 days

Defined as the time interval from enrollment to discharge from ICU or death.

Trial Locations

Locations (1)

Beijing Shijitan Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath